These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 29605203)

  • 21. Efficacy and safety of ipratropium bromide plus fenoterol inhaled via Respimat Soft Mist Inhaler vs. a conventional metered dose inhaler plus spacer in children with asthma.
    von Berg A; Jeena PM; Soemantri PA; Vertruyen A; Schmidt P; Gerken F; Razzouk H
    Pediatr Pulmonol; 2004 Mar; 37(3):264-72. PubMed ID: 14966821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of tiotropium Respimat
    Graham LM; Kerstjens HAM; Vogelberg C; Hamelmann E; Szefler SJ; Pisternick-Ruf W; Engel M; El Azzi G; Unseld A; Foggs MB
    Respir Med; 2019 Aug; 155():58-60. PubMed ID: 31302579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oronasal and Tracheostomy Delivery of Soft Mist and Pressurized Metered-Dose Inhalers With Valved Holding Chamber.
    Berlinski A; Cooper B
    Respir Care; 2016 Jul; 61(7):913-9. PubMed ID: 27006348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of patients' real-world post-dispensing use and storage environments of tiotropium bromide Respimat® soft mist inhaler on its in vitro dose delivery and lung deposition.
    Ammari WG; Khalil Mohammad M; Tayyem RF
    Pulm Pharmacol Ther; 2019 Oct; 58():101829. PubMed ID: 31352077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and tolerability of once-daily tiotropium Respimat(®) as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysis.
    Dahl R; Engel M; Dusser D; Halpin D; Kerstjens HAM; Zaremba-Pechmann L; Moroni-Zentgraf P; Busse WW; Bateman ED
    Respir Med; 2016 Sep; 118():102-111. PubMed ID: 27578478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of tiotropium in children aged 1-5 years with persistent asthmatic symptoms: a randomised, double-blind, placebo-controlled trial.
    Vrijlandt EJLE; El Azzi G; Vandewalker M; Rupp N; Harper T; Graham L; Szefler SJ; Moroni-Zentgraf P; Sharma A; Vulcu SD; Sigmund R; Chawes B; Engel M; Bisgaard H
    Lancet Respir Med; 2018 Feb; 6(2):127-137. PubMed ID: 29361462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro performance characteristics of valved holding chamber and spacer devices with a fluticasone metered-dose inhaler.
    Asmus MJ; Liang J; Coowanitwong I; Hochhaus G
    Pharmacotherapy; 2004 Feb; 24(2):159-66. PubMed ID: 14998215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of large- and small-volume valved holding chambers with a new combination long-term bronchodilator/anti-inflammatory formulation delivered by pressurized metered dose inhaler.
    Nagel MW; Wiersema KJ; Bates SL; Mitchell JP
    J Aerosol Med; 2002; 15(4):427-33. PubMed ID: 12581509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of switching tiotropium HandiHaler® to Respimat® Soft Mist™ Inhaler in patients with COPD: the difference of adverse events and usability between inhaler devices.
    Asakura Y; Nishimura N; Maezawa K; Terajima T; Kizu J; Chohnabayashi N
    J Aerosol Med Pulm Drug Deliv; 2013 Feb; 26(1):41-5. PubMed ID: 22691112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort
    Gillen M; Forte P; Svensson JO; Lamarca R; Burke J; Rask K; Larsdotter Nilsson U; Eckerwall G
    Pulm Pharmacol Ther; 2018 Oct; 52():7-17. PubMed ID: 30077809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The systemic exposure to inhaled beclometasone/formoterol pMDI with valved holding chamber is independent of age and body size.
    Govoni M; Piccinno A; Lucci G; Poli G; Acerbi D; Baronio R; Singh D; Kuna P; Chawes BL; Bisgaard H
    Pulm Pharmacol Ther; 2015 Feb; 30():102-9. PubMed ID: 24746942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative in vitro performance of valved holding chambers with a budesonide/formoterol pressurized metered-dose inhaler.
    Chambers FE; Brown S; Ludzik AJ
    Allergy Asthma Proc; 2009; 30(4):424-32. PubMed ID: 19772764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-Term Once-Daily Tiotropium Respimat® Is Well Tolerated and Maintains Efficacy over 52 Weeks in Patients with Symptomatic Asthma in Japan: A Randomised, Placebo-Controlled Study.
    Ohta K; Ichinose M; Tohda Y; Engel M; Moroni-Zentgraf P; Kunimitsu S; Sakamoto W; Adachi M
    PLoS One; 2015; 10(4):e0124109. PubMed ID: 25894430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety, tolerability, and plasma exposure of tiotropium Respimat® in children and adults with cystic fibrosis.
    Konstan MW; Sharma A; Moroni-Zentgraf P; Wang F; Koker P
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):137-44. PubMed ID: 25380193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of efficiency and preference of metal and plastic spacers in preschool children.
    Amirav I; Tiosano T; Chamny S; Chirurg S; Oren S; Grossman Z; Kahan E; Newhouse MT; Mansour Y;
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):249-52. PubMed ID: 15478384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antistatic treatment and salbutamol dosing have variable effect on drug delivery of valved holding chambers.
    Csonka P; Lehtimäki L
    Pulm Pharmacol Ther; 2019 Dec; 59():101857. PubMed ID: 31678460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Once-daily tiotropium Respimat(®) 5 μg is an efficacious 24-h bronchodilator in adults with symptomatic asthma.
    Timmer W; Moroni-Zentgraf P; Cornelissen P; Unseld A; Pizzichini E; Buhl R
    Respir Med; 2015 Mar; 109(3):329-38. PubMed ID: 25661281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving usability and maintaining performance: human-factor and aerosol-performance studies evaluating the new reusable Respimat inhaler.
    Dhand R; Eicher J; Hänsel M; Jost I; Meisenheimer M; Wachtel H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():509-523. PubMed ID: 30880941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homemade valved holding chambers for children with airway hyperresponsiveness: A randomized crossover trial.
    Chaicoming K; Preutthipan A; Adirekkittikun A; Nugboon M
    Pediatr Pulmonol; 2021 Jan; 56(1):49-56. PubMed ID: 33150727
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Real-Time Analysis of the Respiratory Flow Through a Valved Holding Chamber.
    Curran E; Porée T; Rubin BK
    J Aerosol Med Pulm Drug Deliv; 2020 Aug; 33(4):205-213. PubMed ID: 32101063
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.